newsfilter
← Latest News
GlobeNewswire·

VYNE Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

BRIDGEWATER, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company"), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative, and